These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
637 related items for PubMed ID: 24803084
1. New compounds hybrids 1h-1,2,3-triazole-quinoline against Plasmodium falciparum. Boechat N, Ferreira Mde L, Pinheiro LC, Jesus AM, Leite MM, Júnior CC, Aguiar AC, de Andrade IM, Krettli AU. Chem Biol Drug Des; 2014 Sep; 84(3):325-32. PubMed ID: 24803084 [Abstract] [Full Text] [Related]
2. 1H-1,2,3-Triazole-tethered isatin-7-chloroquinoline and 3-hydroxy-indole-7-chloroquinoline conjugates: synthesis and antimalarial evaluation. Raj R, Gut J, Rosenthal PJ, Kumar V. Bioorg Med Chem Lett; 2014 Feb 01; 24(3):756-9. PubMed ID: 24424135 [Abstract] [Full Text] [Related]
3. Synthesis and evaluation of the antiplasmodial activity of novel indeno[2,1-c]quinoline derivatives. Barteselli A, Parapini S, Basilico N, Mommo D, Sparatore A. Bioorg Med Chem; 2014 Nov 01; 22(21):5757-65. PubMed ID: 25311562 [Abstract] [Full Text] [Related]
4. Novel Quinolinyl-pyrrolo[3,4-d]pyrimidine-2,5-dione Derivatives Against Chloroquine-resistant Plasmodium falciparum. Rogerio KR, Graebin CS, Pinto Domingues LH, Oliveira LS, de Souza Fernandes da Silva V, Daniel-Ribeiro CT, Carvalho LJM, Boechat N. Curr Top Med Chem; 2020 Nov 01; 20(2):99-110. PubMed ID: 31648638 [Abstract] [Full Text] [Related]
5. In vitro antimalarial activity, β-haematin inhibition and structure-activity relationships in a series of quinoline triazoles. Joshi MC, Wicht KJ, Taylor D, Hunter R, Smith PJ, Egan TJ. Eur J Med Chem; 2013 Nov 01; 69():338-47. PubMed ID: 24077524 [Abstract] [Full Text] [Related]
6. Design, synthesis and in vitro antiplasmodial activity of some bisquinolines against chloroquine-resistant strain. Kondaparla S, Agarwal P, Srivastava K, Puri SK, Katti SB. Chem Biol Drug Des; 2017 Jun 01; 89(6):901-906. PubMed ID: 27896925 [Abstract] [Full Text] [Related]
7. 4-aminoquinoline-triazine-based hybrids with improved in vitro antimalarial activity against CQ-sensitive and CQ-resistant strains of Plasmodium falciparum. Manohar S, Khan SI, Rawat DS. Chem Biol Drug Des; 2013 May 01; 81(5):625-30. PubMed ID: 23331618 [Abstract] [Full Text] [Related]
12. Synthesis and antiplasmodial evaluation of 1H-1,2,3-triazole grafted 4-aminoquinoline-benzoxaborole hybrids and benzoxaborole analogues. Saini A, Kumar S, Raj R, Chowdhary S, Gendrot M, Mosnier J, Fonta I, Pradines B, Kumar V. Bioorg Chem; 2021 Apr 01; 109():104733. PubMed ID: 33618251 [Abstract] [Full Text] [Related]
13. Antiplasmodial activity of new 4-aminoquinoline derivatives against chloroquine resistant strain. Sinha M, Dola VR, Agarwal P, Srivastava K, Haq W, Puri SK, Katti SB. Bioorg Med Chem; 2014 Jul 15; 22(14):3573-86. PubMed ID: 24906512 [Abstract] [Full Text] [Related]
14. Synthesis and antimalarial evaluation of novel isocryptolepine derivatives. Whittell LR, Batty KT, Wong RP, Bolitho EM, Fox SA, Davis TM, Murray PE. Bioorg Med Chem; 2011 Dec 15; 19(24):7519-25. PubMed ID: 22055713 [Abstract] [Full Text] [Related]
15. Anti-Plasmodium falciparum activity of quinoline-sulfonamide hybrids. Pinheiro LC, Boechat N, Ferreira Mde L, Júnior CC, Jesus AM, Leite MM, Souza NB, Krettli AU. Bioorg Med Chem; 2015 Sep 01; 23(17):5979-84. PubMed ID: 26190461 [Abstract] [Full Text] [Related]
16. New quinoline-5,8-dione and hydroxynaphthoquinone derivatives inhibit a chloroquine resistant Plasmodium falciparum strain. Hussain H, Specht S, Sarite SR, Hoerauf A, Krohn K. Eur J Med Chem; 2012 Aug 01; 54():936-42. PubMed ID: 22781704 [Abstract] [Full Text] [Related]